An outbreak of Plasmodium falciparum malaria in U.S. marines deployed to Liberia

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 2, 2010, Pages 258-265

  Whitman, Timothy J ^a   Coyne, Philip E ^c   Magill, Alan J ^b   Blazes, David L ^a   Green, Michael D ^d   Milhous, Wilbur K ^e   Burgess, Timothy H ^f   Freilich, Daniel ^f   Tasker, Sybil A ^a   Azar, Ramzy G ^a   Endy, Timothy P ^g   Clagett, Christopher D ^h   Deye, Gregory A ^b   Shanks, G Dennis ⁱ   Martin, Gregory J ^c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f NAVAL MEDICAL RESEARCH CENTER   (United States)

^g State University of New York Upstate Medical University: College of Medicine   (United States)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁱ AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INSECT REPELLENT; MEFLOQUINE; PERMETHRIN;

ADULT; ANTIMALARIAL DRUG RESISTANCE; ARMY; ARTICLE; EPIDEMIC; HUMAN; LIBERIA; MAJOR CLINICAL STUDY; MALARIA; MALE; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM;

ADULT; ANIMALS; ANTIMALARIALS; DISEASE OUTBREAKS; HUMANS; INSECT REPELLENTS; LIBERIA; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MILITARY PERSONNEL; MOSQUITO CONTROL; MOSQUITO NETS; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; PROTECTIVE CLOTHING; UNITED STATES; YOUNG ADULT;

HEXAPODA; PLASMODIUM FALCIPARUM;

EID: 77955632568     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.09-0774     Document Type: Article

References (42)

1. Beadle C, Hoffman SL, 1993. History of malaria in the United States Naval Forces at war: World War I though the Vietnam Conflict. Clin Infect Dis 16: 320-329.
2. Porter WD, 2006. Imported malaria and conflict: 50 years of experience in the U.S. Military. Mil Med 171: 925-928.
3. Kotwal RS, Wenzel RB, Sterling RA, Porter WD, Jordan NN, Petruccelli BP, 2005. An outbreak of malaria in US Army Rangers returning from Afghanistan. JAMA 293: 212-216.
4. Newton JA, Schnepf GA, Wallace MR, Lobel HO, Kennedy CA, Oldfield EC. 1994. Malaria in U.S. Marines returning from Somalia. JAMA 272: 397-399.
5. Wallace MR, Sharp TW, Smoak B, Iriye C, Rozmajzl P, Thornton SA, Batchelor R, Magill AJ, Lobel HO, Longer CF, Burans JP, 1996. Malaria among United States troops in Somalia. Am J Med 100: 49-55.
6. Whitelaw K, 2003. Liberia's plea for help. US News and World Report. July 14, 2003.
7. White NJ, 1998. Why is it that antimalarial drug treatments do not always work? Ann Trop Med Parasitol 92: 449-458.
8. BBC Weather Center. World weather. Average conditions - Monrovia. Available at: http://www.bbc.co.uk/weather/world/city-guides/results.shtml?tt= TT000310. Accessed March 1, 2010.
9. World Health Organization, 2009. World Malaria Report 2009. Available at: http://whqlibdoc.who.int/publications/2009/9789241563901-eng.pdf. Accessed March 28, 2010.
10. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI, 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434: 214-217.
11. Hay SI, Guerra CA, Tatem AJ, Atkinson PM, Snow RW, 2005. Urbanization, malaria transmission and disease burden in Africa. Nature 3: 81-90.
12. Bossi P, Tegnell A, Baka A, Van Loock F, Hendriks J, Werner A, Maidhof H, Gouvras G, 2004. Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses. Euro Surveill 9: E11-E12.
13. Centers for Disease Control and Prevention, 1995. Update: management of patients with suspected viral hemorrhagic fever - United States. MMWR Morb Mortal Wkly Rep 44: 475-479.
14. Ogub O, Ajuluchukwu E, Uneke CJ, 2007. Lassa fever in West African sub-region: an overview. J Vector Borne Dis 44: 1-11.
15. Susi B, Whitman T, Blazes DL, Burgess TH, Martin GJ, Freilich D, 2005. Rapid diagnostic test for Plasmodium falciparum in 32 Marines medically evacuated from Liberia with a febrile illness. Ann Intern Med 142: 476-477.
16. Todd GD, Hopperus Buma AP, Green MD, Jaspers CA, Lobel HO, 1997. Comparison of whole blood and serum levels of mefloquine and its carboxylic acid metabolite. Am J Trop Med Hyg 57: 399-402.
17. Green MD, Bergqvist Y, Mount DL, Corbett S, D'Souza MJ, 1999. Improved validated assay for the determination of mefloquine and its carboxy metabolite in plasma, serum and whole blood using solid-phase extraction and high-performance liquid chromatography. J Chromatography B 727: 159-165.
18. Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC, 1993. Long-term malaria prophylaxis with weekly mefloquine. Lancet 341: 848-851.
19. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16: 710-718.
20. Oduola AM, Weatherly NF, Bowdre JH, Desjardins RE, 1988. Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro. Exp Parasitol 66: 86-95.
21. Price RN, Cassar C, Brockman A, Duraisingh M, van Vugt M, White NJ, Nosten F, Krishna S, 1999. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob Agents Chemother 43: 2943-2949.
22. Jahrling PB, Niklasson BS, McCormick JB, 1985. Early diagnosis of human Lassa fever by ELISA detection of antigen and antibody. Lancet 1: 250-252.
23. Niklasson BS, Jahrling PB, Peters CJ, 1984. Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent asssy. J Clin Microbiol 20: 239-244.
24. U.S. Food and Drug Administration; Center for Drug Evaluation and Research. Mefloquine Hydrochloride Abbreviated New Drug Application 76,175. February 20, 2002.
25. Bartelloni PJ, Sheey TW, Tigertt WD, 1967. Combined therapy for chloroquine-resistant Plasmodium falciparum infection. JAMA 199: 141-145.
26. Tuck JJH, Green AD, Roberts KL, 2003. A malaria outbreak following a British military deployment to Sierra Leone. J Infect 47: 225-230.
27. Migliani R, Josse R, Hovette P, Keundjian A, Pages F, Meynard JB, Ollivier L, Sbai Idrissi K, Tifratene K, Orlandi E, Rogier C, Boutin JP, 2003. Malaria in military personnel: the case of the Ivory Coast in 2002-2003. Med Trop (Mars) 63: 282-286.
28. Phillips-Howard PA, Radalowicz A, Mitchell J, Bradley DJ, 1990. Risk of malaria in British residents returning from malarious areas. BMJ 300: 499-503.
29. World Health Organization, 2000. Severe falciparum malaria: World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 94 (Suppl 1): S1-S90.
30. U.S. Centers for Disease Control and Prevention, 2008. Treatment of Malaria (Guidelines for Clinicians). Available at: http://www.cdc.gov/malaria/ pdf/clinicalguidance.pdf. Accessed September 9, 2008.
31. U.S. Army, 1999. FORSCOM standing logistics instruction. Headquarters UAFC, ed. Volume FORSCOM Regulation 700-2. Fort McPherson, GA: U.S. Army.
32. Rowland M, Downey G, Rab A, Freeman T, Mohammad N, Rehman H, Durrani N, Reyburn H, Curtis C, Lines J, Fayaz M, 2004. DEET mosquito repellent provides personal protection against malaria: a household randomized trial in an Afghan refugee camp in Pakistan. Trop Med Int Health 9: 335-342.
33. D'Alessandro U, Olaleye B, McGuire W, Langerock P, Bennett S, Aikins MK, Thomson MC, Cham MK, Cham BA, Greenwood BM, 1995. Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bed net programme. Lancet 345: 479-483.
34. Navy and Marine Corps Public Health Center, 2007. Technical Manual NEHC-TM PM 6250.1. Navy Medical Guide to Malaria Prevention and Control. Portsmouth, VA: Navy and Marine Corps Public Health Center.
35. Department of Defense. Neuropsychiatric Effects of Mefloquine. Available at: http://www.nytimes.com/2002/08/24/us/army-to-press-medical-inquiry-at-fort- bragg.html?scp=3&sq=Fort%20bragg%20malaria&st=cse. Accessed May 17, 2010.
36. Bourdreau E, Schuster B, Sanchez J, Novakowski W, Johnson R, Redmond D, Hanson R, Dausel L, 1993.Tolerability of prophylactic Lariam regimens. Trop Med Parasitol 44: 257-265.
37. Oduola AM, Milhous WK, Salako LA, Walker O, Desjardins RE, 1987. Reduced in-vitro susceptibility to mefloquine in west African isolates of Plasmodium falciparum. Lancet 2: 1304-1305.
38. Lobel HO, Varma JK, Miani M, Green M, Todd GD, Grady K, Barber AM, 1998. Monitoring for mefloquine-resistant Plasmodium falciparum in Africa: implications for travelers' health. Am J Trop Med Hyg 59: 129-132.
39. Raccurt CP, Dumestre-Toulet V, Abraham E, Le Bras M, Brachet-Liermain A, Ripert C, 1991. Failure of falciparum malaria prophylaxis by mefloquine in travelers from west Africa. Am J Trop Med Hyg 45: 319-324.
40. Peel SA, Bright P, Yount B, Handy J, Baric RS, 1994. A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro. Am J Trop Med Hyg 51: 648-658.
41. Slim W, 1956. Defeat Into Victory. London: Cassell.
42. Department of Defense, 2008. Department of Defense Instruction 6200.02. February 27, 2008: Application of Food and Drug Administration (FDA) Rules to Department of Defense Force Health Protection Programs. Washington, DC: Department of Defense.